Capitan Orthopedics was granted Breakthrough Device Designation from FDA for its SupraSpacer implant. The device is a long-term option designed to restore joint alignment and enable pain-free range of motion while preserving future surgical options.
Chance Leonard, CEO of Capitan Orthopedics, Inc., commented, “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer implant technology. This is yet another milestone achievement for our team and this designation validates the significant unmet medical need.”
Capitan Orthopedics was granted Breakthrough Device Designation from FDA for its SupraSpacer implant. The device is a long-term option designed to restore joint alignment and enable pain-free range of motion while preserving future surgical options.
Chance Leonard, CEO of Capitan Orthopedics, Inc., commented, "I am excited to announce that...
Capitan Orthopedics was granted Breakthrough Device Designation from FDA for its SupraSpacer implant. The device is a long-term option designed to restore joint alignment and enable pain-free range of motion while preserving future surgical options.
Chance Leonard, CEO of Capitan Orthopedics, Inc., commented, “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer implant technology. This is yet another milestone achievement for our team and this designation validates the significant unmet medical need.”
Copy to clipboard 
